Saliha Harrach

Muenster, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process.

CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process.

Journal: Cancer gene therapy

Published: March 08, 2023

Interaction of Masitinib with Organic Cation Transporters.

Interaction of Masitinib with Organic Cation Transporters.

Journal: International journal of molecular sciences

Published: October 11, 2022

Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13-Targeted Tissue Factor tTF-NGR in Advanced Malignant Disease.

Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13-Targeted Tissue Factor tTF-NGR in Advanced Malignant Disease.

Journal: Cancers

Published: October 18, 2021

Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction.

Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction.

Journal: Cancers

Published: May 19, 2021

Animal Safety, Toxicology, and Pharmacokinetic Studies According to the ICH S9 Guideline for a Novel Fusion Protein tTF-NGR Targeting Procoagulatory Activity into Tumor Vasculature: Are Results Predictive for Humans?

Animal Safety, Toxicology, and Pharmacokinetic Studies According to the ICH S9 Guideline for a Novel Fusion Protein tTF-NGR Targeting Procoagulatory Activity into Tumor Vasculature: Are Results Predictive for Humans?

Journal: Cancers

Published: October 29, 2020

First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study.

First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study.

Journal: Cancers

Published: May 18, 2020

Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma.

Radiation synergizes with antitumor activity of CD13-targeted tissue factor in a HT1080 xenograft model of human soft tissue sarcoma.

Journal: PloS one

Published: June 01, 2019

Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma.

Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma.

Journal: Translational oncology

Published: August 06, 2018

Notch Signaling Activity Determines Uptake and Biological Effect of Imatinib in Systemic Sclerosis Dermal Fibroblasts.

Notch Signaling Activity Determines Uptake and Biological Effect of Imatinib in Systemic Sclerosis Dermal Fibroblasts.

Journal: The Journal of investigative dermatology

Published: February 15, 2018

Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer.

Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer.

Journal: PloS one

Published: August 10, 2017

CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancer.

CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: July 01, 2017

Potential therapeutic impact of CD13 expression in non-small cell lung cancer.

Potential therapeutic impact of CD13 expression in non-small cell lung cancer.

Journal: PloS one

Published: January 28, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026